MAPT and Alzheimer disease: The THY-Tau22 mouse model, which over-expresses human 4-repeat tau with G272V and P301S mutations that were originally identified in frontotemporal dementia (FTD) patients [13], offers a valuable tool for studying mechanisms relevant to tauopathies, such as FTD and AD [14].